New Diabetes Medication, Researches Are On! 
Diabetes is one the most common diseases that people suffer from all over the world. It can be an epidemic if not kept under control. Therefore, new diabetes medications keep on popping up regularly. Some of these new diabetes medications are coming very effective. We shall discuss some of these new diabetes medications in detail here.

Among a host of medicines available in the market lately, Januvia is an oral new diabetes medication which has been approved by the Food and Drug Administration of the United States. Januvia consists of sitagliptin phosphate which falls under the category of DPP-4 inhibitors. Januvia is especially formulated for people who have type 2 diabetes which cannot be controlled by diet management or exercise or any other common medication system. Thus, this new diabetes medication can be of great help to you if you are looking for something above the regular exercise regimen and diet control in order to regulate your blood levels.

Another new diabetes medication is selling by the brand name Symlin. Symlin is made of Pramlintide which is a synthetic form of amylin hormone. The blood glucose is regulated by the collaborative work of insulin, amylin and glucagons and when injected in the body, this can improve the A1C level but it does not lead to weight gain. On the other hand, it can lead to weight loss to some degree.

However, this new diabetes medication called Pramlintide cannot be taken with insulin. Due to its chemical complications, pramlintide must be taken using a separate syringe. Pramlintide can be taken by people with Type 1 or Type 2 diabetes. This new diabetes medication is meant for the patients who are not able to meet their A1C goals.

The third new diabetes medication that we shall discuss here is being sold by the name of Byetta which is made of Exenatide. It is a first of its kind diabetes medication. Exenatide comes from the new drug category of drugs meant for type 2 diabetes patients. This new diabetes medication category is called incretin mimetics. Exenatide increases insulin secretion from within the body. Exenatide is intelligent enough to raise insulin secretion levels only when the blood glucose levels are extremely high. Thus, the risk of hypoglycemia remains. Make it a point that if taken along with sulfonylurea, Exenatide may cause a risk of Hypoglycemia.

Exenatide is new diabetes medication which has to be taken with food and can lead to moderate weight loss just like Pramlintide. Exenatide is meant for people who are not able to achieve A1C levels despite consuming sulfonylurea, metformin or a combination of the two.

There are lots of researches going on for diabetes medication and you might have a more effective diabetes medication with lesser side effects in a while.


Related Articles